These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 9105570)

  • 1. Serum complement and familial combined hyperlipidemia.
    Ylitalo K; Porkka KV; Meri S; Nuotio I; Suurinkeroinen L; Vakkilainen J; Pajukanta P; Viikari JS; Peltonen L; Ehnholm C; Taskinen MR
    Atherosclerosis; 1997 Mar; 129(2):271-7. PubMed ID: 9105570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed and exaggerated postprandial complement component 3 response in familial combined hyperlipidemia.
    Meijssen S; van Dijk H; Verseyden C; Erkelens DW; Cabezas MC
    Arterioscler Thromb Vasc Biol; 2002 May; 22(5):811-6. PubMed ID: 12006395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum C3 but not plasma acylation-stimulating protein is elevated in Finnish patients with familial combined hyperlipidemia.
    Ylitalo K; Pajukanta P; Meri S; Cantor RM; Mero-Matikainen N; Vakkilainen J; Nuotio I; Taskinen MR
    Arterioscler Thromb Vasc Biol; 2001 May; 21(5):838-43. PubMed ID: 11348883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationships among acylation stimulating protein, adiponectin and complement C3 in lean vs obese type 2 diabetes.
    Yang Y; Lu HL; Zhang J; Yu HY; Wang HW; Zhang MX; Cianflone K
    Int J Obes (Lond); 2006 Mar; 30(3):439-46. PubMed ID: 16302015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender differences in postprandial ketone bodies in normolipidemic subjects and in untreated patients with familial combined hyperlipidemia.
    Halkes CJ; van Dijk H; Verseyden C; de Jaegere PP; Plokker HW; Meijssen S; Erkelens DW; Cabezas MC
    Arterioscler Thromb Vasc Biol; 2003 Oct; 23(10):1875-80. PubMed ID: 12933534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of atorvastatin on fasting and postprandial complement component 3 response in familial combined hyperlipidemia.
    Verseyden C; Meijssen S; van Dijk H; Jansen H; Castro Cabezas M
    J Lipid Res; 2003 Nov; 44(11):2100-8. PubMed ID: 12923226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperlipidemia and serum complement.
    Cucuianu M
    Atherosclerosis; 1998 Apr; 137(2):441-2. PubMed ID: 9622289
    [No Abstract]   [Full Text] [Related]  

  • 8. C3, hormone-sensitive lipase, and peroxisome proliferator-activated receptor gamma expression in adipose tissue of familial combined hyperlipidemia patients.
    Ylitalo K; Nuotio I; Viikari J; Auwerx J; Vidal H; Taskinen MR
    Metabolism; 2002 May; 51(5):664-70. PubMed ID: 11979403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased fasting plasma acylation-stimulating protein concentrations in nephrotic syndrome.
    Ozata M; Oktenli C; Gulec M; Ozgurtas T; Bulucu F; Caglar K; Bingol N; Vural A; Ozdemir IC
    J Clin Endocrinol Metab; 2002 Feb; 87(2):853-8. PubMed ID: 11836332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence of insulin resistant lipid metabolism in adipose tissue in familial combined hyperlipidemia, but not type 2 diabetes mellitus.
    van der Kallen CJ; Voors-Pette C; Bouwman FG; Keizer HA; Lu JY; van de Hulst RR; Bianchi R; Janssen MJ; Keulen ET; Boeckx WD; Rotter JI; de Bruin TW
    Atherosclerosis; 2002 Oct; 164(2):337-46. PubMed ID: 12204806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A critical evaluation of the putative role of C3adesArg (ASP) in lipid metabolism and hyperapobetalipoproteinemia.
    Kildsgaard J; Zsigmond E; Chan L; Wetsel RA
    Mol Immunol; 1999; 36(13-14):869-76. PubMed ID: 10698341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased plasma levels of oxysterols, in vivo markers of oxidative stress, in patients with familial combined hyperlipidemia: reduction during atorvastatin and fenofibrate therapy.
    Arca M; Natoli S; Micheletta F; Riggi S; Di Angelantonio E; Montali A; Antonini TM; Antonini R; Diczfalusy U; Iuliano L
    Free Radic Biol Med; 2007 Mar; 42(5):698-705. PubMed ID: 17291993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carotid artery intima-media thickness in Finnish families with familial combined hyperlipidemia.
    Ylitalo K; Syvänne M; Salonen R; Nuotio I; Taskinen MR; Salonen JT
    Atherosclerosis; 2002 May; 162(1):171-8. PubMed ID: 11947911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma acylation stimulating protein concentration and subcutaneous adipose tissue C3 mRNA expression in nondiabetic and type 2 diabetic men.
    Koistinen HA; Vidal H; Karonen SL; Dusserre E; Vallier P; Koivisto VA; Ebeling P
    Arterioscler Thromb Vasc Biol; 2001 Jun; 21(6):1034-9. PubMed ID: 11397716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mice lacking acylation stimulating protein (ASP) have delayed postprandial triglyceride clearance.
    Murray I; Sniderman AD; Cianflone K
    J Lipid Res; 1999 Sep; 40(9):1671-6. PubMed ID: 10484614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired activation of adipocyte lipolysis in familial combined hyperlipidemia.
    Reynisdottir S; Eriksson M; Angelin B; Arner P
    J Clin Invest; 1995 May; 95(5):2161-9. PubMed ID: 7738184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial combined hyperlipidemia and hyperlipoprotein(a) as phenotypic mimics of familial hypercholesterolemia: Frequencies, associations and predictions.
    Ellis KL; Pang J; Chan DC; Hooper AJ; Bell DA; Burnett JR; Watts GF
    J Clin Lipidol; 2016; 10(6):1329-1337.e3. PubMed ID: 27919349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weight gain in relation to plasma levels of complement factor 3: results from a population-based cohort study.
    Engström G; Hedblad B; Janzon L; Lindgärde F
    Diabetologia; 2005 Dec; 48(12):2525-31. PubMed ID: 16283247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FAMILIAL COMBINED HYPERLIPIDEMIA: CURRENT KNOWLEDGE, PERSPECTIVES, AND CONTROVERSIES.
    Bello-Chavolla OY; Kuri-García A; Ríos-Ríos M; Vargas-Vázquez A; Cortés-Arroyo JE; Tapia-González G; Cruz-Bautista I; Aguilar-Salinas CA
    Rev Invest Clin; 2018; 70(5):224-236. PubMed ID: 30307446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nutrition, body weight and deterioration of familial combined hyperlipidemia.
    Koprovicová J; Kollár J; Petrásová D
    Coll Antropol; 2006 Dec; 30(4):777-82. PubMed ID: 17243549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.